New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints and observed subgroups New open-label extension analyses demonstrate sustained endoscopic outcomes over time with SKYRIZI, even in patients with complex disease characteristics and prior treatment exposure In real-world studies, patients with advanced Crohn's disease achieved disease control with RINVOQ, highlig

Key Highlights: Tegoprazan is the first and only P-CAB reported to demonstrate clinical improvement in both hallmark symptoms of NERD, heartburn and regurgitation, in a prospective U.S. phase 3 clinical trial. Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both doses of tegoprazan produced statistically significant improvements in the percentage of 24-hour heartburn free days and days without nighttime heartburn versus placebo

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active Crohn's disease and ulcerative colitis Late-breaking analysis shows significantly higher rates of clinical remission and improved endoscopic outcomes with subcutaneous versus intravenous infliximab in patients with ileum-dominant Crohn's disease JERSEY CITY, N.J., Oct. 11, 2026 /PRNewswire/ -- Celltri

Separate FDA submissions report mean small-bowel capsule review-time reductions of 88.6% with ProScan-assisted reading and 24.7% with a recently cleared comparator AI-assisted workflow. PLANO, Texas, Oct. 11, 2026 /PRNewswire/ -- AnX Robotica today highlighted the documented results of clinical performance of NaviCam® ProScan™, its AI-assisted capsule endoscopy reading technology, following a recent U.S. Food and Drug Administration clearance of another AI-assisted capsule endoscopy platform. In

A simple change in the order you eat your food could help prevent blood sugar spikes. Scientists discovered that giving mice olive oil before carbohydrates slowed digestion and activated a surprising combination of hormones and nerve signals that helped regulate blood sugar, even in mice with type 2 diabetes.The order in which you eat different foods may have a surprising effect on blood sugar levels. Research in mice suggests that consuming fat before carbohydrates can reduce the sharp rise in

Scientists have discovered a hidden cleanup system at the back of the eye that drains fluid and waste through a previously unknown pathway. The surprising finding, demonstrated in mice, could open the door to new treatments for glaucoma, macular degeneration, and other causes of blindness.Scientists have uncovered a previously unknown cleanup system at the back of the eye, revealing a hidden route that allows fluid and waste to escape into the body's lymphatic system. The discovery challenges lo

MASON, Ohio, Oct. 10, 2026 /PRNewswire/ -- Haag-Streit USA and Marco Lombart, an Advancing Eyecare company and the exclusive U.S. distributor of Haag-Streit's Octopus perimetry range, today announce the U.S. launch of the Octopus 910. The full-field projection perimeter will make its U.S. debut at AAO 2026, taking place from October 10 to 12, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. Octopus 910, see it first at AAO 2026 Continue Reading Octopus 910 Perimeter Vis

New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems HIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), today announced that Chief Medical Officer Thomas Strack, M.D., Ph.D., presented research spotlighting hypoglycemia-related burdens among adults with T1D

BOULDER, Colo., Oct. 10, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Blink Single-Use Custom Packs offering and a first-of-its-kind automated manufacturing process for Sharpoint® microsurgical knives at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting taking place October 10 - 12 in New Orleans. These new ophthalmic advancements represent Corza Medical's continued investments to bring together g

NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The posters highlight new preclinic